505 Stock Overview
An investment holding company, provides healthcare services in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
AsiaMedic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.011 |
| 52 Week High | S$0.014 |
| 52 Week Low | S$0.009 |
| Beta | 1.02 |
| 1 Month Change | 10.00% |
| 3 Month Change | 0% |
| 1 Year Change | 10.00% |
| 3 Year Change | -42.11% |
| 5 Year Change | 10.00% |
| Change since IPO | -97.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 505 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -8.3% | -0.9% | 0.08% |
| 1Y | 10.0% | -17.6% | 0.8% |
Return vs Industry: 505 exceeded the SG Healthcare industry which returned -17.6% over the past year.
Return vs Market: 505 exceeded the SG Market which returned 0.8% over the past year.
Price Volatility
| 505 volatility | |
|---|---|
| 505 Average Weekly Movement | 11.1% |
| Healthcare Industry Average Movement | 8.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 13.9% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 505 has not had significant price volatility in the past 3 months.
Volatility Over Time: 505's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of SG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Arifin Kosumo Kwek Zhi Bin | www.asiamedic.com.sg |
AsiaMedic Limited, an investment holding company, provides healthcare services in Singapore. The company offers diagnostic imaging, radiology, health screening, and medical wellness services. It also provides medical aesthetic products and related services.
AsiaMedic Limited Fundamentals Summary
| 505 fundamental statistics | |
|---|---|
| Market cap | S$12.70m |
| Earnings (TTM) | S$1.92m |
| Revenue (TTM) | S$23.75m |
6.6x
P/E Ratio0.5x
P/S RatioIs 505 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 505 income statement (TTM) | |
|---|---|
| Revenue | S$23.75m |
| Cost of Revenue | S$18.40m |
| Gross Profit | S$5.35m |
| Other Expenses | S$3.43m |
| Earnings | S$1.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0017 |
| Gross Margin | 22.52% |
| Net Profit Margin | 8.09% |
| Debt/Equity Ratio | 4.5% |
How did 505 perform over the long term?
See historical performance and comparison